Home LiteratureArticle Details
PMID: 8510207 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120.

Journal of virology ·Vol. 67 ·No. 7 ·1993-07-00 ·Pages 3818-25

Fu YK, Hart TK, Jonak ZL, Bugelski PJ

Abstract

The mechanism of CD4-mediated fusion via activated human immunodeficiency virus type 1 (HIV-1) gp41 and the biological significance of soluble CD4 (sCD4)-induced shedding of gp120 are poorly understood. The purpose of these investigations was to determine whether shedding of gp120 led to fusion activation or inactivation. BJAB cells (TF228.1.16) stably expressing HIV-1 envelope glycoproteins (the gp120-gp41 complex) were used to examine the effects of pH and temperature on sCD4-induced shedding of gp120 and on cell-to-cell fusion (syncytium formation) with CD4+ SupT1 cells. sCD4-induced shedding of gp120 was maximal at pH 4.5 to 5.5 and did not occur at pH 8.5. At physiologic pH, sCD4-induced shedding of gp120 occurred at 22, 37, and 40 degrees C but neither at 16 nor 4 degrees C. In contrast, syncytia formed at pH 8.5 (maximally at pH 7.5) but not at pH 4.5 to 5.5. At pH 7.5, syncytia formed at 37 and 40 degrees C but not at 22, 16, or 4 degrees C. Preincubation of cocultures of TF228.1.16 and SupT1 cells at 4, 16, or 22 degrees C before the shift to 37 degrees C resulted in similar, increased, or decreased syncytium formation, respectively, compared with the control. Furthermore, an activated intermediate of CD4-gp120-gp41 ternary complex may form at 16 degrees C; this intermediate rapidly executes fusion upon a shift to 37 degrees C but readily decays upon a shift to the shedding-permissive but fusion-nonpermissive temperature of 22 degrees C. These physicochemical data indicate that shedding of HIV-1 gp120 is not an integral step in the fusion cascade and that CD4 may inactivate the fusion complex in a process analogous to sCD4-induced shedding of gp120.

MeSH Terms
CD4 Antigens/chemistry,metabolism Cell Fusion Cell Line Giant Cells HIV Envelope Protein gp120/metabolism HIV-1/metabolism Humans Hydrogen-Ion Concentration In Vitro Techniques Receptors, Virus/metabolism Solubility Temperature
Chemicals
CD4 Antigens HIV Envelope Protein gp120 Receptors, Virus
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Fu Y K
SmithKline Beecham Pharmaceuticals, Toxicology-U.S., King of Prussia, Pennsylvania 19406-0939.
Hart T K
Jonak Z L
Bugelski P J
References (61)
61 references, click to expand
  1. Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41.
    Proc Natl Acad Sci U S A. 1990 Jun;87(12):4650-4 PMID: 2191297
  2. Strong association of simian immunodeficiency virus (SIVagm) envelope glycoprotein heterodimers: possible role in receptor-mediated activation.
    AIDS Res Hum Retroviruses. 1992 Dec;8(12):2011-20 PMID: 1493051
  3. CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells.
    J Virol. 1990 Oct;64(10):5194-8 PMID: 2398542
  4. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding.
    J Exp Med. 1990 Oct 1;172(4):1233-42 PMID: 1698911
  5. Soluble CD4 enhances simian immunodeficiency virus SIVagm infection.
    J Virol. 1990 Dec;64(12):6252-6 PMID: 1700834
  6. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
    Science. 1990 Nov 23;250(4984):1139-42 PMID: 2251501
  7. Intermediates in influenza induced membrane fusion.
    EMBO J. 1990 Dec;9(13):4231-41 PMID: 2265606
  8. Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission.
    J Exp Med. 1991 Feb 1;173(2):511-4 PMID: 1671082
  9. Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and their neutralization by soluble CD4.
    J Virol. 1991 Mar;65(3):1133-40 PMID: 1995942
  10. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.
    Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2189-93 PMID: 2006155
  11. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
    AIDS Res Hum Retroviruses. 1991 Jan;7(1):3-16 PMID: 2015114
  12. On the entry of Semliki forest virus into BHK-21 cells.
    J Cell Biol. 1980 Feb;84(2):404-20 PMID: 6991511
  13. Phagosome-lysosome fusion. Characterization of intracellular membrane fusion in mouse macrophages.
    J Cell Biol. 1980 Jun;85(3):754-65 PMID: 7391139
  14. Adsorptive endocytosis of Semliki Forest virus.
    J Mol Biol. 1980 Sep 25;142(3):439-54 PMID: 7463480
  15. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion.
    Proc Natl Acad Sci U S A. 1982 Feb;79(4):968-72 PMID: 6951181
  16. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.
    Nature. 1984 Dec 20-1985 Jan 2;312(5996):763-7 PMID: 6096719
  17. The activation of the human neutrophil respiratory burst occurs only at temperatures above 17 degrees C: evidence that activation requires membrane fusion.
    Biochem Biophys Res Commun. 1985 Oct 30;132(2):696-701 PMID: 2998379
  18. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
    Science. 1986 Jan 24;231(4736):382-5 PMID: 3001934
  19. AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen.
    Science. 1986 May 30;232(4754):1123-7 PMID: 3010463
  20. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.
    Nature. 1986 Oct 23-29;323(6090):725-8 PMID: 3095663
  21. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.
    Cell. 1987 Jun 5;49(5):659-68 PMID: 3107838
  22. A human lymphoid recombinant cell line with functional human immunodeficiency virus type 1 envelope.
    AIDS Res Hum Retroviruses. 1993 Jan;9(1):23-32 PMID: 8094000
  23. Effects of mutations in three domains of the vesicular stomatitis viral glycoprotein on its lateral diffusion in the plasma membrane.
    J Cell Biol. 1987 Jul;105(1):69-75 PMID: 3038931
  24. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.
    Cell. 1987 Sep 11;50(6):975-85 PMID: 2441877
  25. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.
    Science. 1987 Sep 11;237(4820):1351-5 PMID: 3629244
  26. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.
    Science. 1987 Dec 18;238(4834):1704-7 PMID: 3500514
  27. HIV infection is blocked in vitro by recombinant soluble CD4.
    Nature. 1988 Jan 7;331(6151):76-8 PMID: 2829022
  28. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
    Nature. 1988 Jan 7;331(6151):78-81 PMID: 2829023
  29. A soluble form of CD4 (T4) protein inhibits AIDS virus infection.
    Nature. 1988 Jan 7;331(6151):82-4 PMID: 3257544
  30. Soluble CD4 molecules neutralize human immunodeficiency virus type 1.
    Nature. 1988 Jan 7;331(6151):84-6 PMID: 2829024
  31. Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism.
    EMBO J. 1988 Feb;7(2):513-8 PMID: 3259178
  32. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.
    Cancer Res. 1988 Sep 1;48(17):4827-33 PMID: 3409223
  33. Quantitative measurement of fusion between human immunodeficiency virus and cultured cells using membrane fluorescence dequenching.
    FEBS Lett. 1988 Oct 24;239(1):88-92 PMID: 2846352
  34. Identification of the fusion peptide of primate immunodeficiency viruses.
    Science. 1989 May 12;244(4905):694-7 PMID: 2541505
  35. Structure and function of the HIV envelope.
    AIDS. 1989;3 Suppl 1:S35-41 PMID: 2482055
  36. Enhancement of SIV infection with soluble receptor molecules.
    Science. 1990 Mar 2;247(4946):1084-8 PMID: 2309120
  37. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.
    J Exp Med. 1991 Aug 1;174(2):407-15 PMID: 1713252
  38. Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity.
    J Virol. 1991 Sep;65(9):5007-12 PMID: 1870209
  39. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
    Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8082-6 PMID: 1896455
  40. Receptor-mediated activation of immunodeficiency viruses in viral fusion.
    Science. 1991 May 31;252(5010):1322-3 PMID: 1925547
  41. Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes.
    AIDS Res Hum Retroviruses. 1991 Oct;7(10):799-805 PMID: 1742075
  42. Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.
    J Virol. 1992 Jan;66(1):132-8 PMID: 1727475
  43. Investigation of human immunodeficiency virus fusion peptides. Analysis of interrelations between their structure and function.
    AIDS Res Hum Retroviruses. 1992 Jan;8(1):9-18 PMID: 1736943
  44. Kinetics of HIV-1 interactions with sCD4 and CD4+ cells: implications for inhibition of virus infection and initial steps of virus entry into cells.
    Virology. 1992 Apr;187(2):398-406 PMID: 1347667
  45. Temperature enhancement of syncytium formation by HIV and Sendai virus.
    J Med Virol. 1992 Jan;36(1):44-8 PMID: 1315369
  46. Conformational alteration of Sindbis virion glycoproteins induced by heat, reducing agents, or low pH.
    J Virol. 1992 Jun;66(6):3504-13 PMID: 1374808
  47. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4.
    J Virol. 1992 Jun;66(6):3531-7 PMID: 1583722
  48. Thermodynamic and kinetic analysis of sCD4 binding to HIV-1 virions and of gp120 dissociation.
    AIDS Res Hum Retroviruses. 1992 Apr;8(4):443-50 PMID: 1599754
  49. HIV interactions with CD4: a continuum of conformations and consequences.
    Immunol Today. 1992 Jun;13(6):201-6 PMID: 1627247
  50. Tracking of cell surface receptors by fluorescence digital imaging microscopy using a charge-coupled device camera. Low-density lipoprotein and influenza virus receptor mobility at 4 degrees C.
    J Cell Sci. 1992 Feb;101 ( Pt 2):415-25 PMID: 1629253
  51. A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells.
    J Virol. 1992 Aug;66(8):4784-93 PMID: 1378510
  52. The human immunodeficiency virus gp120 binding site on CD4: delineation by quantitative equilibrium and kinetic binding studies of mutants in conjunction with a high-resolution CD4 atomic structure.
    J Exp Med. 1992 Aug 1;176(2):507-17 PMID: 1500858
  53. High level of surface CD4 prevents stable human immunodeficiency virus infection of T-cell transfectants.
    J Virol. 1992 Sep;66(9):5492-9 PMID: 1501285
  54. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
    J Virol. 1992 Sep;66(9):5516-24 PMID: 1501286
  55. Localized conformational changes in the N-terminal domain of CD4 identified in competitive binding assay of monoclonal antibodies and HIV-1 envelope glycoprotein.
    AIDS Res Hum Retroviruses. 1992 Jun;8(6):1083-90 PMID: 1503822
  56. Human immunodeficiency virus type 1 envelope glycoprotein molecules containing membrane fusion-impairing mutations in the V3 region efficiently undergo soluble CD4-stimulated gp120 release.
    J Virol. 1992 Oct;66(10):6208-12 PMID: 1527858
  57. CD4 changes conformation upon ligand binding.
    J Immunol. 1992 Dec 1;149(11):3596-604 PMID: 1431129
  58. Membrane fusion of Semliki Forest virus involves homotrimers of the fusion protein.
    J Virol. 1992 Dec;66(12):7309-18 PMID: 1433520
  59. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.
    Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10792-6 PMID: 1438278
  60. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120.
    Virology. 1992 Dec;191(2):732-42 PMID: 1280382
  61. The effect of temperature on the binding kinetics and equilibrium constants of monoclonal antibodies to cell surface antigens.
    Mol Immunol. 1990 Apr;27(4):327-33 PMID: 2359411
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1993-07-00
Pages
3818-25
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC237746
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com